Cargando…
Effects of low-dose tamoxifen on breast cancer biomarkers Ki-67, estrogen and progesterone receptors
Breast carcinoma is the most common malignancy among women and it has a major impact on mortality. Studies of primary chemoprevention with tamoxifen have generated high expectations and considerable success rates. The efficacy of lower doses of tamoxifen is similar to that seen with a standard dose...
Autores principales: | , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1578575/ https://www.ncbi.nlm.nih.gov/pubmed/16972993 http://dx.doi.org/10.1186/1477-7800-3-29 |